Annual Working Capital
$730.63 M
+$189.79 M+35.09%
December 31, 2024
Summary
- As of March 6, 2025, AKRO annual working capital is $730.63 million, with the most recent change of +$189.79 million (+35.09%) on December 31, 2024.
- During the last 3 years, AKRO annual working capital has risen by +$562.17 million (+333.72%).
- AKRO annual working capital is now at all-time high.
Performance
AKRO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$730.63 M
+$27.03 M+3.84%
December 31, 2024
Summary
- As of March 6, 2025, AKRO quarterly working capital is $730.63 million, with the most recent change of +$27.03 million (+3.84%) on December 31, 2024.
- Over the past year, AKRO quarterly working capital has increased by +$27.03 million (+3.84%).
- AKRO quarterly working capital is now -17.07% below its all-time high of $881.02 million, reached on March 31, 2024.
Performance
AKRO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AKRO Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +35.1% | +3.8% |
3 y3 years | +333.7% | +333.7% |
5 y5 years | +467.8% | +467.8% |
AKRO Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +333.7% | -17.1% | +401.0% |
5 y | 5-year | at high | +467.8% | -17.1% | +610.7% |
alltime | all time | at high | >+9999.0% | -17.1% | +969.8% |
Akero Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $730.63 M(+35.1%) | $730.63 M(+3.8%) |
Sep 2024 | - | $703.60 M(-5.5%) |
Jun 2024 | - | $744.84 M(-15.5%) |
Mar 2024 | - | $881.02 M(+62.9%) |
Dec 2023 | $540.83 M(+60.9%) | $540.83 M(-1.2%) |
Sep 2023 | - | $547.53 M(-11.9%) |
Jun 2023 | - | $621.60 M(+87.9%) |
Mar 2023 | - | $330.81 M(-1.6%) |
Dec 2022 | $336.09 M(+99.5%) | $336.09 M(-4.7%) |
Sep 2022 | - | $352.70 M(+124.0%) |
Jun 2022 | - | $157.45 M(+8.0%) |
Mar 2022 | - | $145.84 M(-13.4%) |
Dec 2021 | $168.45 M | $168.45 M(-15.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $198.27 M(-9.8%) |
Jun 2021 | - | $219.76 M(-10.5%) |
Mar 2021 | - | $245.64 M(-4.9%) |
Dec 2020 | $258.23 M(+100.7%) | $258.23 M(-9.7%) |
Sep 2020 | - | $286.02 M(+178.2%) |
Jun 2020 | - | $102.80 M(-12.8%) |
Mar 2020 | - | $117.93 M(-8.4%) |
Dec 2019 | $128.68 M(+72.1%) | $128.68 M(-10.2%) |
Sep 2019 | - | $143.35 M(-9.5%) |
Jun 2019 | - | $158.37 M(+131.9%) |
Mar 2019 | - | $68.30 M(-8.7%) |
Dec 2018 | $74.79 M(>+9900.0%) | $74.79 M |
Dec 2017 | $416.00 K | - |
FAQ
- What is Akero Therapeutics annual working capital?
- What is the all time high annual working capital for Akero Therapeutics?
- What is Akero Therapeutics annual working capital year-on-year change?
- What is Akero Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Akero Therapeutics?
- What is Akero Therapeutics quarterly working capital year-on-year change?
What is Akero Therapeutics annual working capital?
The current annual working capital of AKRO is $730.63 M
What is the all time high annual working capital for Akero Therapeutics?
Akero Therapeutics all-time high annual working capital is $730.63 M
What is Akero Therapeutics annual working capital year-on-year change?
Over the past year, AKRO annual working capital has changed by +$189.79 M (+35.09%)
What is Akero Therapeutics quarterly working capital?
The current quarterly working capital of AKRO is $730.63 M
What is the all time high quarterly working capital for Akero Therapeutics?
Akero Therapeutics all-time high quarterly working capital is $881.02 M
What is Akero Therapeutics quarterly working capital year-on-year change?
Over the past year, AKRO quarterly working capital has changed by +$27.03 M (+3.84%)